A Resource Guide to Investing in Biotechnology
Directory - Encyclopedia - Stock Index - Drugs  

Biotech100 Stock Index

Barrier Therapeutics

About Barrier Therapeutics

Barrier Therapeutics is a biopharmaceutical company focused on the discovery, development and commercialization of a portfolio of innovative pharmaceutical products to address major medical needs in the field of dermatology. Barrier Therapeutics currentlyhas multiple product candidates in clinical development, with four of these candidates in or entering Phase III clinical trials.


Pipeline Chart Barrier Therapeutics

Pipeline Description


Zimycan™. antifungal agent
Sebazole™. antifungal agent
Liarozoleoral treatment for congenital ichthyosis
Hyphanox™ fungal infections, including vaginal candidiasis


More on Barrier Therapeutics

Home Page

Key Statistics for Barrier Therapeutics

Basic Chart for Barrier Therapeutics

Analyst Opinion

Analysts Estimates


Biotech100 Index
· What are the Requirements to be listed in the Biotech100 Index?
· See the Biotech100 List

Sponsored Links

Clinical Trials
· What is a Clinical Trial?
·Phase I ,-- Phase II, -- PhaseIII
·What is Randomized Control?
 What is a Double Blind Experiment?
·What is the role of the FDA?


Key Biotech Terms


Biotech Resources


Investing in Stocks
· Small Cap Stocks
· Stocks and Bonds
· Biotech100 Index

Careers and Employment
· Biotechnology and Pharmaceutical
· What are the Fastest Growing Careers?




Copyright © 2005 BIOTECH100.COM. All rights reserved.